In fact, the FDA just approved tirzepatide (Zepbound) in December 2024 as the first medication specifically for treating sleep apnea in adults with obesity
He described feeling less sluggish, especially after meals, and more motivated to stay active
Any change in appearance, including crystallization, precipitation, or color change, indicates that the medication should not be used and should be returned to the pharmacy for proper disposal
Additionally, patients experienced modest weight loss averaging 2 to 3 kg over 6 months, an unexpected but welcome effect that distinguished GLP-1 receptor agonists from many other diabetes medications that cause weight gain
So although weight loss might be the vehicle, it's not usually the destination
We look at the GLP-1 consumption, cost benefits, data over the past 10 years, and the truth is that they didn't really see this coming. Dai said the top two producers for these medications, Novo Nordisk and Eli Lilly, are spending a respective $10 billion and $2 billion to expand their production capacities and meet demand